{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:12:55Z","timestamp":1789668775075,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152985","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:49:57Z","timestamp":1776610197000},"page":"152985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epicardial fat as a cardiovascular risk factor in inflammatory arthritis"],"prefix":"10.1016","volume":"78","author":[{"given":"Shubhabrata","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Weir-McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6074-2968","authenticated-orcid":false,"given":"Elsie T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.semarthrit.2026.152985_bib0001","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152985_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0003319718814309","article-title":"The relationship of ankylosing spondylitis and subclinical atherosclerosis: a systemic review and meta-analysis","volume":"70","author":"Bai","year":"2019","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152985_bib0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.semarthrit.2016.05.012","article-title":"Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same?","volume":"46","author":"Coates","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152985_bib0004","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152985_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2026.152985_bib0006","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/annrheumdis-2021-eular.3622","article-title":"POS1010\u2005Predicting cardiovascular events in patients with spondyloarthritis: 3 risk algorithms","volume":"80","author":"Pinto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0007","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijcard.2018.09.089","article-title":"Epicardial adipose tissue and cardiovascular diseases","volume":"278","author":"Ansaldo","year":"2019","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152985_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jcct.2013.01.002","article-title":"Quantification of epicardial fat by computed tomography: why, when and how?","volume":"7","author":"Marwan","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0009","first-page":"182","article-title":"Impaired left ventricular diastolic functions and thickened epicardial adipose tissue in rheumatoid arthritis patients is correlated with DAS-28 score","volume":"33","author":"Alpayd\u0131n","year":"2017","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4314\/ahs.v15i2.23","article-title":"Epicardial fat thickness in patients with rheumatoid arthritis","volume":"15","author":"Fatma","year":"2015","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/art.41693","article-title":"Epicardial adipose tissue volume as a marker of subclinical coronary atherosclerosis in rheumatoid arthritis","author":"Karpouzas","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/782850","article-title":"Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies","volume":"2014","author":"Lima-Mart\u00ednez","year":"2014","journal-title":"Arthritis"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152985_bib0013","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/acr.22027","article-title":"Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis","volume":"65","author":"Ormseth","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152985_bib0014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.11152\/mu-2001","article-title":"The relationship between epicardial adipose tissue and arterial stiffness in patients with rheumatoid arthritis","volume":"21","author":"Petra","year":"2019","journal-title":"Med Ultrason"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2026.152985_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00059-014-4140-z","article-title":"Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: associations in rheumatoid arthritis patients","volume":"40","author":"Temiz","year":"2015","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10641963.2020.1833025","article-title":"Assessment of arterial stiffness and epicardial adipose tissue thickness in predicting the subclinical atherosclerosis in patients with ankylosing spondylitis","volume":"43","author":"Demir","year":"2021","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10067-014-2568-4","article-title":"Epicardial adipose tissue thickness in patients with ankylosing spondylitis","volume":"34","author":"Resorlu","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/BMR-160650","article-title":"Epicardial adipose tissue thickness as a new risk factor for atherosclerosis in patients with ankylosing spondylitis","volume":"32","author":"Surucu","year":"2019","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152985_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152985_bib0020","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0021","unstructured":"DAPSA calculator. https:\/\/rheuma.charite.de\/fileadmin\/user_upload\/microsites\/ohne_AZ\/m_cc13\/rheuma\/Templates\/DAPSA_ENGpdf. Accessed 24 August 2021."},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152985_bib0022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0023","unstructured":"ASDAS calculator. https:\/\/www.asas-group.org\/instruments\/asdas-calculator\/. Accessed 24 August 2021."},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152985_bib0024","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152985_bib0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the national heart, lung, and blood Institute\/American heart association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"Supplement 1","key":"10.1016\/j.semarthrit.2026.152985_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American association of clinical endocrinologists and AMERICAN college of endocrinology \u2013 CLINICAL practice guidelines for developing a diabetes mellitus comprehensive care plan \u20132015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0027","unstructured":"FraminghamRiskCalculator. Framingham risk calculator. https:\/\/qxmd.com\/calculate\/calculator_252\/framingham-risk-score-2008. Accessed on 2 April 2020."},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152985_bib0028","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0029","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0030","unstructured":"Vital Images M., USA. Vitrea\u00ae cardiac demonstrations (Vitrea\u00ae cardiac demonstrations). Accessed 2 April 2020."},{"key":"10.1016\/j.semarthrit.2026.152985_bib0031","unstructured":"https:\/\/ca.medical.canon\/products\/computed-tomography\/aq_one_genesis. CT scanner for coronary calcium scoring. Accessed 2nd April 2020."},{"key":"10.1016\/j.semarthrit.2026.152985_bib0032","unstructured":"Terarecon. CT cardiac advanced visualization package | Terarecon. https:\/\/www.terarecon.com\/advanced-visualization\/ct-cardiac. Accessed on 30 May 2021."},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152985_bib0033","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152985_bib0034","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/art.40925","article-title":"Value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease","volume":"71","author":"Sobchak","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152985_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5606\/ArchRheumatol.2016.5867","article-title":"Evaluation of atrial conduction times, epicardial fat thickness and carotid intima-Media thickness in patients with ankylosing spondylitis","volume":"31","author":"\u00c7a\u011flar","year":"2016","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12944-016-0271-y","article-title":"Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152985_bib0037","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjcard.2012.08.044","article-title":"Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome","volume":"111","author":"Pierdomenico","year":"2013","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152985_bib0038","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/met.2013.0107","article-title":"The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis","volume":"12","author":"Rabkin","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152985_bib0039","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1007\/s00330-015-3765-5","article-title":"Prognostic value of epicardial fat volume measurements by computed tomography: a systematic review of the literature","volume":"25","author":"Spearman","year":"2015","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152985_bib0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ehjci\/jex314","article-title":"Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis","volume":"19","author":"Mancio","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.semarthrit.2026.152985_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152833","article-title":"Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort","volume":"75","author":"Llorca","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152985_bib0042","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152985_bib0043","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ecn.2011.0294","article-title":"Cytokine network in psoriasis revisited","volume":"22","author":"Michalak-Stoma","year":"2011","journal-title":"Eur Cytokine Netw"},{"issue":"10 Suppl 1","key":"10.1016\/j.semarthrit.2026.152985_bib0044","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:59:26Z","timestamp":1789667966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0049017226000740"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152985","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epicardial fat as a cardiovascular risk factor in inflammatory arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152985"}}